Treatment Patterns and Outcomes in Lenalidomide-Exposed Multiple Myeloma Patients in Real-World Settings: A Multi-Center Retrospective Study

被引：0
|
作者：
Couto, Maria Eduarda [1 ]
Borges, Marina [1 ]
Bento, Maria Jose [1 ]
Daniela, Rita Calisto Marta [1 ]
Magalhaes, Marques [1 ]
Ajmal, Adil
Niklas, Nicolas [2 ]
Dushkin, Kirill [2 ]
MacDougall, Finaly [2 ]
Wolf, Andrea [3 ]
mShabid, Shabana [3 ]
vonMetzler, Ivana [4 ]
机构：
[1] Portuguese Oncol Inst Porto, Porto, Portugal
[2] IQVIA Ltd, London, England
[3] Goethe Univ, Univ Hosp Frankfurt, Univ Canc Ctr, Frankfurt, Germany
[4] Goethe Univ, Univ Hosp Frankfurt, Dept Med, Hematol Oncol, Frankfurt, Germany
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-148724
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5012
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Phase 1b/2 Study of Carfilzomib, Pomalidomide, and Dexamethasone (KPd) in Patients (Pts) with Lenalidomide-Exposed and/or -Refractory but Proteasome Inhibitor (PI)-Naive or -Sensitive Multiple Myeloma: A Multiple Myeloma Research Consortium Multi-Center Study
    Rosenbaum, Cara A.
    Kukreti, Vishal
    Zonder, Jeffrey
    Lebovic, Daniel
    Zimmerman, Todd
    Berdeja, Jesus G.
    McDonnell, Kathryn
    Waite-Marin, Jessica
    Griffith, Kent A.
    Jakubowiak, Andrzej
    BLOOD, 2014, 124 (21)
  • [22] Real-World Treatment Patterns and Outcomes in Patients with NSCLC in England (ROSANNE): A Retrospective Study
    Greystoke, A.
    Nawaz, A.
    Ferguson, S.
    Pabla, M.
    Sanjeevi, P.
    Bar-Ziv, O.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S299 - S300
  • [23] Key Drivers for Treatment Choice in Lenalidomide-Exposed and Refractory Multiple Myeloma Patients in the Real World. Analysis Conducted in the EU5 Countries and the US
    Nicolas, Blin
    Mai, Christine
    Ertl, Siegfried
    Schneider, Elodie
    Leberre, Marine
    Yilmaz, Melissa
    Raffy, Alexandre
    BLOOD, 2024, 144 : 2403 - 2404
  • [24] Real-World Treatment Patterns and Outcomes of Triple-Exposed Multiple Myeloma (MM) Patients Treated in Community Oncology Practices in the US
    Smith, Robert
    Xue, Mei
    Dorrow, Natalie
    Varughese, Prateesh
    Hogea, Cosmina
    Buckingham, Trudy
    Sansbury, Leah
    Ferrante, Shannon
    Maiese, Eric M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S419 - S420
  • [25] REAL-WORLD EXPERIENCE OF LENALIDOMIDE/DEXAMETHASONE TREATMENT FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM) PATIENTS
    Tognazzi, L.
    Rivolti, E.
    Quaresima, M.
    Labbozzetta, S.
    Gamberi, B.
    Merli, F.
    HAEMATOLOGICA, 2017, 102 : 137 - 137
  • [26] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
    María José Cejalvo
    Gabriela Bustamante
    Esther González
    Judith Vázquez-Álvarez
    Ricarda García
    Ángel Ramírez-Payer
    Ernesto Pérez-Persona
    Eugenia Abella
    Sebastián Garzón
    Antoni García
    Isidro Jarque
    Marta Sonia González
    Antonia Sampol
    Cristina Motlló
    Josep María Martí
    Magdalena Alcalá
    Rafael Duro
    Yolanda González
    José Luis Sastre
    Josep Sarrà
    Giselle Lostaunau
    Rocío López
    Javier de la Rubia
    Annals of Hematology, 2021, 100 : 1769 - 1778
  • [27] Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
    Cejalvo, Maria Jose
    Bustamante, Gabriela
    Gonzalez, Esther
    Vazquez-Alvarez, Judith
    Garcia, Ricarda
    Ramirez-Payer, Angel
    Perez-Persona, Ernesto
    Abella, Eugenia
    Garzon, Sebastian
    Garcia, Antoni
    Jarque, Isidro
    Gonzalez, Marta Sonia
    Sampol, Antonia
    Motllo, Cristina
    Marti, Josep Maria
    Alcala, Magdalena
    Duro, Rafael
    Gonzalez, Yolanda
    Sastre, Jose Luis
    Sarra, Josep
    Lostaunau, Giselle
    Lopez, Rocio
    de la Rubia, Javier
    ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1769 - 1778
  • [28] Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
    Shebli Atrash
    Evelyn M. Flahavan
    Tao Xu
    Esprit Ma
    Sudeep Karve
    Wan-Jen Hong
    Gilbert Jirau-Lucca
    Michael Nixon
    Sikander Ailawadhi
    Blood Cancer Journal, 12
  • [29] Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
    Atrash, Shebli
    Flahavan, Evelyn M.
    Xu, Tao
    Ma, Esprit
    Karve, Sudeep
    Hong, Wan-Jen
    Jirau-Lucca, Gilbert
    Nixon, Michael
    Ailawadhi, Sikander
    BLOOD CANCER JOURNAL, 2022, 12 (03)
  • [30] Real-World Treatment Patterns and Outcomes Among Multiple Myeloma Patients with Asthma and COPD in the United States
    Megan S. Rice
    Sarah Naeger
    Erin Singh
    Oncology and Therapy, 2021, 9 : 195 - 212
12345